| 英文别名 |
Momelotinib dihydrochloride;CYT387 dihydrochloride;RBH995N496;Momelotinib dihydrochloride [USAN];Momelotinib dihydrochloride (USAN);N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide;dihydrochloride;N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide,dihydrochloride;N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide,dihydrochloride;Momelotinib HCl;Momelotinib 2HCl;Momelotinibdihydrochl;D10358;DTXSID00160456;UNII-RBH995N496;Benzamide, N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)-, hydrochloride (1:2);MOMELOTINIB DIHYDROCHLORIDE [WHO-DD];CYT-387 dihydrochloride;Q27288045;CHEMBL2219411;1380317-28-1;GLXC-10946;Momelotinibdihydrochloride;N-(Cyanomethyl)-4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)benzamide dihydrochloride;SB14601;SCHEMBL15873859;CS-0056511;D85535;DTXCID0082947;Benzamide, N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)-, dihydrochloride |